Glaxo, Pfizer to Merge Advil and Panadol in Consumer Venture

Glaxo and Pfizer have formed a joint venture, making Glaxo the largest over-the-counter medicine supplier. Glaxo holds 68% of the venture, with plans to list it in three years. This move splits GSK into consumer and medicine businesses. Investors are optimistic about the IPO. The deal reflects a trend of drug companies separating consumer brands. Glaxo has been active, acquiring Novartis's business and selling an Indian subsidiary. Despite some concerns over recent acquisitions, the market has responded positively to the joint venture.

What type of products does the consumer business include?

What is the name of the CEO of Glaxo mentioned in the text?